Free Trial

UpHealth (UPHL) Competitors

$0.0004 +0.00 (+33.33%)
(As of 12/20/2024 04:19 PM ET)

UPHL vs. BTTX, ACONW, AONC, DHACW, CORBF, LFMDP, OTRKP, PIIIW, TALKW, and TOIIW

Should you be buying UpHealth stock or one of its competitors? The main competitors of UpHealth include Better Therapeutics (BTTX), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry.

UpHealth vs.

UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

UpHealth has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500.

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company Overall Sentiment
UpHealth Neutral
Better Therapeutics Neutral

Better Therapeutics has lower revenue, but higher earnings than UpHealth. UpHealth is trading at a lower price-to-earnings ratio than Better Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M-$1.350.00
Better TherapeuticsN/AN/A-$39.76M-$1.150.00

UpHealth's return on equity of 34.37% beat Better Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A 34.37% 9.54%
Better Therapeutics N/A N/A N/A

56.1% of UpHealth shares are held by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Comparatively, 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Better Therapeutics received 5 more outperform votes than UpHealth when rated by MarketBeat users.

CompanyUnderperformOutperform
UpHealthN/AN/A
Better TherapeuticsOutperform Votes
5
41.67%
Underperform Votes
7
58.33%

Summary

Better Therapeutics beats UpHealth on 6 of the 10 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPHL vs. The Competition

MetricUpHealthHealth services IndustryMedical SectorNYSE Exchange
Market Cap$8,000.00$867.07M$5.14B$19.19B
Dividend YieldN/A1.90%5.09%3.61%
P/E Ratio0.0032.2089.8241.30
Price / Sales0.003.751,116.2117.58
Price / CashN/A25.1442.8921.28
Price / Book0.002.924.785.32
Net Income-$56.42M-$5.79M$120.23M$989.88M
7 Day PerformanceN/A-4.93%-1.92%-3.54%
1 Month PerformanceN/A-4.89%11.49%-3.68%
1 Year PerformanceN/A226.77%30.57%12.14%

UpHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPHL
UpHealth
N/A$0.00
+33.3%
N/A-99.8%$8,000.00$130M0.001,750Gap Up
BTTX
Better Therapeutics
N/A$0.00
flat
N/A-99.9%$5,000.00N/A0.0040
ACONW
Aclarion
N/A$0.04
flat
N/A-36.1%$0.00$49,289.000.007Positive News
AONC
American Oncology Network
N/A$4.68
+2.7%
N/A-22.5%$0.00$1.34B0.001,520News Coverage
DHACW
Digital Health Acquisition
N/A$0.06
flat
N/AN/A$0.00N/A0.00N/A
CORBF
Global Cord Blood
N/A$1.26
flat
N/A+15.4%$0.00$196.12M0.001,202High Trading Volume
LFMDP
LifeMD
N/A$22.16
-1.6%
N/A+17.1%$0.00$193.06M0.00230
OTRKP
Ontrak
N/A$0.28
-3.5%
N/A-57.6%$0.00$10.84M0.00250Gap Down
PIIIW
P3 Health Partners
N/A$0.01
-1.2%
N/AN/A$0.00$1.48B0.00500Positive News
TALKW
Talkspace
N/A$0.13
-2.2%
N/A+7.1%$0.00$181.29M0.00500Gap Down
TOIIW
Oncology Institute
N/A$0.01
-1.0%
N/A-95.0%$0.00$378.93M0.00660Positive News

Related Companies and Tools


This page (NYSE:UPHL) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners